Patricia Carr insider trades

Open-market stock purchases and sales by Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Aug 8, 2019.

Recent trades

DateStockTradeValue
Mar 9, 2026JAZZ Jazz Pharmaceuticals plcSold$235K
Mar 5, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$268K
Feb 27, 2026JAZZ Jazz Pharmaceuticals plcSold$213K
Feb 26, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Feb 26, 2026JAZZ Jazz Pharmaceuticals plcSold$243K
Jan 16, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Dec 5, 2025JAZZ Jazz Pharmaceuticals plcSold$27.4K
Dec 5, 2025JAZZ Jazz Pharmaceuticals plcSold$770K
Dec 5, 2025JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Nov 18, 2025JAZZ Jazz Pharmaceuticals plcSold$12.5K
Nov 18, 2025JAZZ Jazz Pharmaceuticals plcSold$956K
Nov 18, 2025JAZZ Jazz Pharmaceuticals plcBought (not open market)—

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 44 sales, last Mar 9, 2026

Get free alerts when Patricia Carr files a new trade →